• Mutual Funds
  • TATA Mutual Fund
  • Tata India Pharma & Healthcare Fund (Growth)
TATA Mutual Fund

Tata India Pharma & Healthcare Fund (Growth)

EquitySectoral / Thematic - Pharma And Healthcare

26.0782

NAV (Jun 11)

24.5%
5 Year CAGR
Scripbox Opinion
Not Recommended
Click here for top ranked funds in sectoral / thematic - pharma and healthcare mutual funds.

Sectoral / thematic - pharma and healthcare funds provides inflation beating growth over the long term and is suitable for investment objectives with duration of 10-15 years or longer (minimum 5 years).

The pharma benchmark index itself has been a material underperformer over an extended time frame.

Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.

Our analysis of this fundLearn how we rate funds ->

Fund Size

Poor

The performance of the fund on a Fund Size metric has been Poor

Outperformance Consistency

Neutral

The performance of the fund on a Outperformance Consistency metric has been Neutral

Scripbox Recommended Equity Funds
Want the equity funds that are right for your long term equity investment needs?Learn more

Investment Calculator

Investment Duration5 years

0

Total Investment

0

Wealth Gained

0

Total Corpus Created (₹)

With CAGR of 11.25 % in 5 years

Historical NAV

26.0782

NAV (Jun 11)

Fund Returns

Last 1Y
51.2%
Last 3Y
15.1%
Last 5Y
24.5%
Last 10Y
NA
Since Inception
12%
6 Month CAGR
20.8%

Scheme Information

Investment Objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However,there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

Expense Ratio
2.25
Launched (9y ago)
Dec 28, 2015
AUM in Crores
899.171
ISIN
INF277K016A9
Lock-in
No Lock-in
Benchmark
Nifty Pharma TR INR
SIP Minimum
1000
Lumpsum Min.
5000
Standard Deviation (3yr)
14.2
Standard Deviation (5yr)
16.8
Beta (3yr)
0.9
Beta (5yr)
0.76
Sharpe Ratio (3yr)
0.659
Sharpe Ratio (5yr)
1.037
YTM
0
Fund Managers

Meeta Shetty

Fund Manager

Important Links

Scheme Information Document

Statement of Additional Information

Portfolio Disclosure

Returns Calculator Comparison

of

for

with step up of

AssetReturnsTotal CorpusGainsCAGR
Tata India Pharma & Healthcare Fund (Growth)70%13,77,456 6,44,84424.5%
EPF70% 9,00,761 1,68,1498.50%
Property70% 8,67,662 1,35,0507.00%
PPF70% 8,69,819 1,37,2077.10%
Bank FD70% 8,46,471 1,13,8596.00%
Gold70% 8,46,471 1,13,8596.00%
Savings Bank70% 8,25,950 93,3385.00%

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.

Asset allocation and Holdings

Last updated on 2024-06-11

Top Stock Holdings

sun pharmaceuticals industries ltd

13.1%
13.1%

aurobindo pharma ltd

9.8%
9.8%

lupin ltd

9%
9%

dr reddy's laboratories ltd

6.9%
6.9%

cipla ltd

6.7%
6.7%
See all holdings

Allocation by Sector

healthcare

94.9%
94.9%

basic materials

2%
2%
See all sectors

Comparison with Equity Funds

Fund NameFund SizeOutperformance Consistency
Mirae Asset ELSS Tax Saver Fund (G)
Mirae Asset ELSS Tax Saver Fund (G)

₹ 22,620 cr

₹ 19,454 cr

₹ 15,161 cr

₹ 42,669 cr

₹ 63,933 cr

amc-img

About the AMC

Tata Asset Management Limited

Tata Asset Management Limited manages assets worth 155,195 crores and was set up on 15 March 1994. It's current offering of mutual fund schemes includes 71 equity,114 debt and 17 hybrid funds.amc-img
phone-img022-66578282
Fund NameScripbox Opinion
Till Date CAGR

12.4%

13.1%

25.9%

26.4%

5.9%

6.7%

18.1%

18.9%

17.5%

19.5%

Tata India Pharma & Healthcare Fund (G) Review

Tata India Pharma & Healthcare Fund (G) is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 12% over a period of 8 years. The fund is managed by Tata Asset Management Limited. The fund manager’s name is Meeta Shetty.

Nav of Tata India Pharma & Healthcare Fund (G) as of 6/11/2024 is ₹26.08 with the total AUM as of 6/12/2024 is ₹899.171. With Scripbox you can compare and check the latest nav for all mutual funds in India. Tata India Pharma & Healthcare Fund (G) was launched on Dec 28, 2015. The category risk of the fund is Very High Risk.

The minimum SIP amount for Tata India Pharma & Healthcare Fund (G) is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.

Tata India Pharma & Healthcare Fund (G) is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to Nifty Pharma TR INR.

Tata India Pharma & Healthcare Fund (G) is rated as a 1 fund in Equity and delivered 51.7% returns in the last 1 year. Scripbox provides a compare mutual funds research tool to view a detailed comparison with Tata India Pharma & Healthcare Fund (G).

Frequently Asked Questions

What is Tata India Pharma & Healthcare Fund (G)?

Tata India Pharma & Healthcare Fund (G) is a Sectoral / Thematic - Pharma And Healthcare Equity scheme predominantly investing across Equity instruments with an investment objective to generate wealth over the long term.

How to invest in Tata India Pharma & Healthcare Fund (G)?

You can invest in Tata India Pharma & Healthcare Fund (G) through AMC, intermediaries, brokers or platforms like Scripbox. To learn step by step process visit how to invest in mutual funds?

What is the minimum sip amount of Tata India Pharma & Healthcare Fund (G)?

The minimum sip amount for Tata India Pharma & Healthcare Fund (G) is ₹1000. You can invest in multiples of ₹5000.

Is Tata India Pharma & Healthcare Fund (G) good to invest in?

As per Scripbox experts, Tata India Pharma & Healthcare Fund (G) is a Not Recommended fund. You can investTata India Pharma & Healthcare Fund (G) fund if its investment objective and risk-o-meter matches your investment goals and risk preferences.

What is the expense ratio of the Tata India Pharma & Healthcare Fund (G)?

The expense ratio of the Tata India Pharma & Healthcare Fund (G) is 2.25% for regular plan.